Category: FDA – Food and Drug Administration

Pulling Back the Curtain: mRNA Lipid Nanoparticle Design Created Potential for Clotting and Triggering Immune Overdrive

In this series, “Promise or Peril: Alarming COVID-19 mRNA Vaccine Issues,” we explore how the introduction of mRNA technology lacked an adequate regulatory framework, setting the stage for serious adverse events and other concerns related to inadequate safety testing of lipid nanoparticles, spike protein, and residual DNA and lipid-related impurities, as well as truncated/modified mRNA…


2 States Propose Ban on 5 Toxic Additives in Food and Candy

California and New York lawmakers have proposed bills to ban five toxic chemical food additives linked to cancer and behavioral and developmental issues in children. Jesse Gabriel (D-Woodland Hills), and Buffy Wicks (D-Sacramento), both members of the California Assembly, proposed Assembly Bill AB 418 in February. The bill is co-sponsored by Consumer Reports and the Environmental Working Group (EWG)….


Robert F. Kennedy Jr. on the Biopharmaceutical Industrial Complex

“You have scientists who are supposed to be regulators, who are making money on the product they’re supposed to be regulating,” says Robert F. Kennedy Jr., the founder and chief legal counsel of Children’s Health Defense and the author of “The Real Anthony Fauci.” In a recent two-part episode of “American Thought Leaders,” host Jan Jekielek sat…


FDA Approves Treatment for Rare Form of ALS

The U.S. Food and Drug Administration (FDA) has approved a drug for treating patients with a rare form of neurological disease called amyotrophic lateral sclerosis (ALS). ALS affects motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle movements like walking, chewing, breathing, and talking. An individual suffering from ALS loses the…


The Surprising Good News From Swiss Authorities: No More COVID-19 Vaccinations

Commentary As a subscriber to Dr. John Campbell’s popular YouTube channel, I sometimes keep the video playing in the background. On April 11, I heard him say that the Swiss authorities have suspended all COVID-19 vaccinations. I was both shocked and surprised. Could this really be the case? As a former scientist who worked at…


Scientists Warn That Baby Formula Shortage Could Happen Again

Former Food and Drug Administration (FDA) officials told the House Oversight subcommittee that factors that led to a shortage of baby formula had been identified but remained unchanged. Witnesses at a March 28 hearing of the Health Care and Financial Services subcommittee said the agency would need more funding, enforcement authority, and a better organizational…


Scientists Warn Baby Formula Shortage Could Happen Again

Former Food and Drug Administration (FDA) officials told the House Oversight subcommittee that factors that led to a shortage of baby formula had been identified but remained unchanged. Witnesses at a March 28 hearing of the Health Care and Financial Services subcommittee said the agency would need more funding, enforcement authority, and a better organizational…


FDA’s Budget Increase Meant to Better Protect Consumers, But US Buyers Must Still Beware

On March 9, the U.S. Food and Drug Administration (FDA) announced its request for $7.2 billion as part of the president’s fiscal year 2024 budget—an increase of 10 percent from 2023’s approved budget. While the agency has more money to perform its duties—including substantial funds from industry—it still leaves a lot of work for average…


Plant-Based Milk Can Be Called ‘Milk’: FDA Proposes Draft Labeling Guidance

Plant-based food companies can now label their alternative milk products, such as oat and almond milk, as “milk,” according to draft labeling recommendations that the U.S. Food and Drug Administration (FDA) released on Feb. 22. But if companies do call their products “milk,” the guidance recommends they should clearly label the beverage’s plant source, such…


FDA Asks Federal Judge to Protect Access to Abortion Drug Mifepristone

The U.S. Food and Drug Administration (FDA) is asking a federal judge to reject a lawsuit seeking to withdraw the approval given to an abortion drug as plaintiffs accuse the agency of failing to follow proper regulatory standards and succumbing to political machinations during the approval process. The lawsuit (pdf), filed by a group of…